Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -16.4 % |
3 Month Return | + 18.86 % |
1 Year Return | + 24.4 % |
Market Stats | |
Previous Close | ₹19.22 |
Open | ₹19.55 |
Volume | 3.73L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹437.15Cr |
P/E Ratio | 26.69 |
PEG Ratio | 190.67 |
Market Cap | ₹437.15 Cr |
P/B Ratio | 2.18 |
EPS | 0.58 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 9.45 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹437.15 Cr | 121.32% | 0.51 | ₹13 Cr | ₹86 Cr | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Gennex Laboratories Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 2.76 Cr → 5.37 Cr (in ₹), with an average increase of 18.4% per quarter
Best in 3 Years
In the last 3 years, Gennex Lab. has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
Revenue is up for the last 2 quarters, 30.79 Cr → 33.38 Cr (in ₹), with an average increase of 7.8% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 18.42% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 81.58% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 34.2%
Price Dip
In the last 1 month, Gennex Lab. stock has moved down by -16.4%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 18.42% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 81.58% | 0.00 | |
Others | 0% | 0.00 |
Gennex Laboratories Ltd in the last 5 years
Lowest (10.10x)
March 23, 2020
Today (26.69x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (86.13x)
August 3, 2018
Gennex Laboratories Ltd’s net profit jumped 74.92% since last year same period to ₹5.37Cr in the Q2 2024-2025. On a quarterly growth basis, Gennex Laboratories Ltd has generated 15.24% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Gennex Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Gennex Laboratories Ltd (531739) share price today is ₹18.96
Gennex Laboratories Ltd is not listed on NSE
Gennex Laboratories Ltd is listed on BSE
PE Ratio of Gennex Laboratories Ltd is 26.69
PE ratio = Gennex Laboratories Ltd Market price per share / Gennex Laboratories Ltd Earnings per share
Today’s traded volume of Gennex Laboratories Ltd(531739) is 3.73L.
Today’s market capitalisation of Gennex Laboratories Ltd(531739) is ₹437.15Cr.
Gennex Laboratories Ltd(531739 | Price |
---|---|
52 Week High | ₹29 |
52 Week Low | ₹13.25 |
Gennex Laboratories Ltd(531739) share price is ₹18.96. It is down -34.62% from its 52 Week High price of ₹29
Gennex Laboratories Ltd(531739) share price is ₹18.96. It is up 43.09% from its 52 Week Low price of ₹13.25
Gennex Laboratories Ltd(531739 | Returns |
---|---|
1 Day Returns | -0.26% |
1 Month Returns | -16.4% |
3 Month Returns | 18.86% |
1 Year Returns | 24.4% |